Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism EGFR T790M inhibitors(Epidermal Growth Factor Receptor T790M inhibitors) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Non-squamous non-small cell lung cancer | Phase 2 | China | 08 May 2025 | |
metastatic non-small cell lung cancer | Phase 2 | China | 22 Feb 2021 | |
Metastatic Non-Squamous Non-Small Cell Lung Carcinoma | IND Approval | China | 30 Sep 2024 | |
Locally Advanced Lung Non-Squamous Non-Small Cell Carcinoma | IND Approval | China | 30 Sep 2024 |